Advertisement
Survey Series
Institutions
For Advertisers
|
|
||||
|
The Outlook for European Biotech in 2005
A number of startups plan to go public and changes could ease the way
Email: Clare Kittredge - ckittredge@the-scientist.com The Scientist 2005, 19(1):37
|
||||
|
|
||||
|
Much like an uncertain weather forecast predicting sun and patchy clouds, industry analysts see mixed prospects for European biotechnology companies in 2005. Geopolitical problems such as the war in Iraq aren't helping to soothe jittery investors, who are traditionally more risk-averse than those in the United States. What's more, Europe has a fragmented marketplace and an overabundance of stock exchanges, which heightens the regulatory burden on companies.
|
|
|||||||||
|
|||||||||
|
